BRVO and CRVO are not the same clinical pathway
A branch retinal vein occlusion affects a retinal venous branch, while a central retinal vein occlusion involves the main retinal vein. The amount of retina affected, visual prognosis, ischemic risk and monitoring needs can therefore differ substantially. The German retina center should receive the exact diagnosis rather than only a generic note saying 'retinal vascular occlusion'.
OCT measures macular edema; angiography helps answer perfusion questions
UKE lists OCT and fluorescein angiography among core retinal diagnostic tools, while University Hospital Cologne also documents OCT, fluorescein angiography and OCT angiography for retinal and macular disease. OCT is especially useful for quantifying retinal fluid and following treatment response; angiographic imaging may be added when retinal perfusion, leakage or neovascularization needs clarification.
Macular edema commonly leads to repeated intravitreal treatment
UKE and University Hospital Cologne document intravitreal treatment for edema caused by retinal vascular occlusion. Anti-VEGF therapy is commonly used and may need repeated treatment over months according to OCT findings and visual response. Selected corticosteroid approaches may also be considered depending on the eye, lens status, pressure risk and previous response.
Laser has a selected role rather than replacing anti-VEGF by default
University Hospital Cologne lists laser therapy for retinal vein occlusion, while the German retina societies maintain a dedicated recommendation for treating vision-reducing macular edema after RVO. The exact role of laser depends on the occlusion type, macular status, ischemia and neovascular complications; it should not be assumed to be the default substitute for indicated intravitreal therapy.
Ischemia and new vessels change the follow-up plan
A severely ischemic retinal vein occlusion can lead to retinal or anterior-segment neovascularization and, in some cases, neovascular glaucoma. Follow-up therefore needs to cover more than OCT fluid alone. Ask the retina specialist what examination schedule is needed to monitor perfusion, new vessels and eye pressure.
Systemic vascular risk assessment is part of sensible planning
A retinal vein occlusion should prompt review of relevant systemic vascular factors with the treating physicians, such as blood pressure, diabetes status, lipid disorders and other cardiovascular or hematologic concerns when clinically appropriate. An eye treatment plan does not replace systemic evaluation.
Prepare a longitudinal record for a German retina review
Serial imaging and the exact injection history are especially useful because treatment decisions depend on disease activity over time.
- Exact diagnosis: BRVO, CRVO or hemi-retinal vein occlusion if documented
- Recent OCT images and reports from both eyes
- Earlier OCT scans for comparison
- Current and previous visual acuity
- Fundus photographs
- Fluorescein or OCT angiography if performed
- Injection history with drug, dates and response
- Any retinal laser treatment and treatment area
- Eye-pressure history and glaucoma history
- Relevant vascular history, blood pressure, diabetes status and current systemic medication
Sudden visual loss still needs prompt local ophthalmic assessment
A new substantial loss of vision, new extensive floaters, eye pain or other acute change should be assessed locally without delaying care for international travel planning. RVO is different from retinal arterial occlusion, but a new visual event still requires timely diagnosis and exclusion of other urgent causes.
Official sources
- Retinal diseases – vascular occlusion, OCT and intravitreal treatment — University Medical Center Hamburg-Eppendorf (UKE) ↗
- Ophthalmology – IVOM, OCT, angiography and retinal vein occlusion — University Hospital Cologne ↗
- Intravitreal injections for retinal and macular disease — University Hospital Cologne ↗
- Intravitreal therapy of vision-reducing macular edema after retinal vein occlusion — German Retina Society / DOG / BVA ↗